Cargando…

Aberrant O‐glycosylation contributes to tumorigenesis in human colorectal cancer

Aberrant O‐glycosylation is frequently observed in colorectal cancer (CRC) patients, but it is unclear if it contributes intrinsically to tumorigenesis. Here, we investigated the biological consequences of aberrant O‐glycosylation in CRC. We first detected the expression profile of Tn antigen in a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yuliang, Liu, Zhe, Xu, Feng, Dong, Xichen, Cheng, Yurong, Hu, Yizhang, Gao, Tianbo, Liu, Jian, Yang, Lei, Jia, Xingyuan, Qian, Haili, Wen, Tao, An, Guangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156240/ https://www.ncbi.nlm.nih.gov/pubmed/29999571 http://dx.doi.org/10.1111/jcmm.13752

Ejemplares similares

T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition
por: Dong, Xichen, et al.
Publicado: (2018)

Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44
por: Du, Tan, et al.
Publicado: (2020)

Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo
por: Wang, Qian, et al.
Publicado: (2016)

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma
por: Cuello, Hector A., et al.
Publicado: (2018)

Drug resistance related to aberrant glycosylation in colorectal cancer
por: Very, Ninon, et al.
Publicado: (2017)

Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations
por: Okayama, Hirokazu, et al.
Publicado: (2018)

Tn antigen promotes human colorectal cancer metastasis via H‐Ras mediated epithelial‐mesenchymal transition activation
por: Liu, Zhe, et al.
Publicado: (2019)

Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity
por: Jusino, Shirley, et al.
Publicado: (2018)

Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer
por: Li, Xuan, et al.
Publicado: (2023)

Involvement of Aberrant Glycosylation in Thyroid Cancer
por: Miyoshi, Eiji, et al.
Publicado: (2010)

Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017)

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
por: Hofmann, Bianca T., et al.
Publicado: (2015)

Aberrant glycosylation associated with enzymes as cancer biomarkers
por: Meany, Danni L, et al.
Publicado: (2011)

∆ DNMT3B4-del Contributes to Aberrant DNA Methylation Patterns in Lung Tumorigenesis
por: Ma, Mark Z., et al.
Publicado: (2015)

Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer
por: Mu, Alan Kang-Wai, et al.
Publicado: (2013)

Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response
por: Madsen, Caroline B., et al.
Publicado: (2012)

Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
por: Lucchetta, Marta, et al.
Publicado: (2019)

Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection
por: Chandrasekar, Dharini, et al.
Publicado: (2023)

Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins
por: Aasted, Mikkel K.M., et al.
Publicado: (2023)

Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
por: Tuccillo, Franca Maria, et al.
Publicado: (2014)

Role of aberrant glycosylation enzymes in oral cancer progression
por: Vajaria, Bhairavi N., et al.
Publicado: (2018)

Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
por: Matsumoto, Yasuyuki, et al.
Publicado: (2023)

Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis
por: Barkeer, Srikanth, et al.
Publicado: (2018)

Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer
por: Zhang, Bo, et al.
Publicado: (2015)

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

Aberrantly expressed microRNAs in the context of bladder tumorigenesis
por: Lee, Jong-Young, et al.
Publicado: (2016)

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin
por: Gong, Fang-Yuan, et al.
Publicado: (2018)

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016)

piR‐823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1
por: Yin, Jie, et al.
Publicado: (2017)

Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis
por: Tandon, Neha, et al.
Publicado: (2019)

LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway
por: Liu, Bing, et al.
Publicado: (2018)

Vibration Induces BAFF Overexpression and Aberrant O-Glycosylation of IgA1 in Cultured Human Tonsillar Mononuclear Cells in IgA Nephropathy
por: Ye, Muyao, et al.
Publicado: (2016)

Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review
por: Sun, Qiang, et al.
Publicado: (2016)

Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway
por: Liu, Bing, et al.
Publicado: (2019)

Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway
por: Liu, Bing, et al.
Publicado: (2019)

The story of O-glycosylation
por: Short, Ben
Publicado: (2010)

O-Glycosylation of snails
por: Stepan, Herwig, et al.
Publicado: (2012)

Ferrocenium complex aided O-glycosylation of glycosyl halides
por: Talasila, Deva Saroja, et al.
Publicado: (2021)

MUC1 O-glycosylation contributes to anoikis resistance in epithelial cancer cells
por: Piyush, Tushar, et al.
Publicado: (2017)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_riorg6bb0e5577nipvov35quc9